Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events

Netherlands Heart Journal

Volumn 17, Issue 4, 2009, Pages 162-168

  Mulder, D J ^a   Van Haelst, P L ^b   Graaff, R ^a   Gans, R O ^a   Zijlstra, F ^a   Smit, A J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Advanced glycation endproducts; Autofluorescence; Inflammation; Myocardial infarction; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; C REACTIVE PROTEIN; HEMOGLOBIN A1C;

ACUTE HEART INFARCTION; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; AUTOFLUORESCENCE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INVASIVE MEASUREMENT; OXIDATIVE STRESS; PREDICTION; SKIN; ST SEGMENT ELEVATION;

EID: 70349270658     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03086239     Document Type: Article

References (34)

1. Stocker R, Keaney J. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84:1381-1478
2. Walter M, Jacob R, Jeffers B, Ghadanfar M, Preston G, Buch J, et al. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiol 2004;44:1996-2002. (Pubitemid 39473284)
3. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104: 2673-2678 (Pubitemid 33108132)
4. Holvoet P, Collen D, Van de Werf F. Malondialdehyde-modified LDL as a marker of acute coronary syndromes. JAMA 1999;281: 1718-1721 (Pubitemid 29226482)
5. Shimomura H, Ogawa H, Takazoe K, Soejima H, Miyamoto S, Sakamoto T, et al. Comparison of urinary biopyrrin levels in acute myocardial infarction (after reperfusion therapy) versus stable angina pectoris and their usefulness in predicting subsequent cardiac events. Am J Cardiol 2002;90:108-111. (Pubitemid 34775116)
6. Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brummer J, et al. Urinary 8-iso-Prostaglandin F2{alpha} as a risk marker in patients with coronary heart disease: A matched case-control study. Circulation 2004; 109:843-848 (Pubitemid 38252735)
7. Smit A, Lutgers H. The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation. Curr Med Chem 2004;11:2767-2784 (Pubitemid 39255562)
8. Baynes JW, Thorpe SR. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 2000;28:1708-1716
9. Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 2005;16:3687-3693 (Pubitemid 46211290)
10. Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans RO, et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007;30:107-112 (Pubitemid 46052507)
11. Mulder DJ, van Haelst PL, Gross S, de LK, Bijzet J, Graaff R, et al. Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products. Atherosclerosis 2007;197:217-223
12. Meerwaldt R, Oomen PHN, Links TP, Gans ROB, Smit AJ, Graaff R, et al. Simple non-invasive assessment of advanced glycation end-product accumulation. Diabetologia 2004;47:1324-1330 (Pubitemid 39093330)
13. Meerwaldt R, Links T, Graaff R, Thorpe SR, Baynes JW, Hartog J, et al. Simple noninvasive measurement of skin autofluorescence. Ann N Y Acad Sci 2005;1043:290-298 (Pubitemid 41123918)
14. Mulder DJ, van Haelst PL, Graaff R, Smit AJ, Gans RO, Zijlstra F. Skin autofluorescence is an independent marker for acute myocardial infarction. Circulation 2005;112:U427.
15. Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. The advanced glycation end product, Nepsilon-(carboxymethyl) lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996;271:9982-9986 (Pubitemid 26132518)
16. Hartog J, de Vries A, Lutgers H, Meerwaldt R, Huisman R, van Son W, et al. Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease. Ann N Y Acad Sci 2005;1043:299-307. (Pubitemid 41123919)
17. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 2006;29:2654-2659 (Pubitemid 44912194)
18. Meerwaldt R, Graaff R, Links T, Baynes JW, Navis G, Huisman R, et al. Skin autofluorescence, a noninvasive measure of advanced glycation end product accumulation, is a predictor of mortality in hemodialysis patients. Ann N Y Acad Sci 2005;1043:911.
19. Valgimigli M, Merli E, Malagutti P, Soukhomovskaia O, Cicchitelli G, Macri G, et al. Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress. Arch Biochem Biophys 2003;420:255-261 (Pubitemid 37491109)
20. Horiuchi M, Tsutsui M, Tasaki H, Morishita T, Suda O, Nakata S, et al. Upregulation of vascular extracellular superoxide dismutase in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol 2004;24:106-111 (Pubitemid 38082419)
21. Wang XL, Adachi T, Sim AS, Wilcken DEL. Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Arterioscler Thromb Vasc Biol 1998;18: 1915-1921 (Pubitemid 28565754)
22. Vassalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 2004;256:308-315 (Pubitemid 39304342)
23. Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004;109:IV6-19.
24. Kanauchi M, Tsujimoto N, Hashimoto T. Advanced glycation end products in nondiabetic patients with coronary artery disease. Diabetes Care 2001;24:1620. (Pubitemid 33716459)
25. Kilhovd BK, Juutilainen A, Lehto S, Ronnemaa T, Torjesen PA, Birkeland KI, et al. High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study. Arterioscler Thromb Vasc Biol 2005;25: 815-820 (Pubitemid 40463875)
26. Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 1998;37: 586-600.
27. Bucciarelli LG, Kaneko M, Ananthakrishnan R, Harja E, Lee LK, Hwang YC, et al. Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury. Circulation 2006; 113:1226-1234 (Pubitemid 43754248)
28. Forbes J, Yee L, Thallas V, Lassila M, Candido R, Jandeleit-Dahm K, et al. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes 2004;53:1813-1823 (Pubitemid 38857040)
29. Park L, Raman K, Lee K, Lu Y, Ferran L, Chow W, et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 1998;4:1025-1031 (Pubitemid 28417334)
30. Wolffenbuttel BHR, Crijns FRL, Huijberts MSP, Swennen GNM, Boulanger CM, Poitevin P et al. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci U S A 1998;95:4630-4634 (Pubitemid 28207964)
31. Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A 2002;99:15596-15601 (Pubitemid 35403978)
32. Liuzzo G, Biasucci LM, Rebuzzi AG, Maseri A, Grillo RL, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424 (Pubitemid 24247397)
33. Mulder DJ, Water TV, Lutgers HL, Graaff R, Gans RO, Zijlstra F, et al. Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther 2006;8:523-535 (Pubitemid 44946877)
34. Odetti P, Pronzato MA, Noberasco G, Cosso L, Traverso N, Cottalasso D, et al. Relationships between glycation and oxidation related fluorescences in rat collagen during aging. An in vivo and in vitro study. Lab Invest 1994;70:61-67 (Pubitemid 24080105)